BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2690476)

  • 1. The nature and origin of alkaline phosphatase in hepatobiliary disease.
    Moss DW
    Z Med Lab Diagn; 1989; 30(7):355-63. PubMed ID: 2690476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of leukocyte alkaline phosphatase in hepato-biliary diseases].
    Dangoumau J; Beraud C; Castets PH; Traissac FJ
    Rev Fr Etud Clin Biol; 1967 Apr; 12(4):367-72. PubMed ID: 6059110
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkaline phosphatase in bile and urine. Excretion in patients with hepatobiliary disease.
    Allen H; Spellberg MA
    Arch Intern Med; 1967 Dec; 120(6):667-71. PubMed ID: 6058402
    [No Abstract]   [Full Text] [Related]  

  • 4. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H; Pfeiffer P; Breuer H
    Z Klin Chem Klin Biochem; 1972 Feb; 10(2):51-5. PubMed ID: 4347073
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diagnostic significance of leucocytic alkaline phosphatase in hepato-biliary diseases].
    Pexa H; Neumayr A
    Acta Hepatosplenol; 1967; 14(6):348-57. PubMed ID: 5598801
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of serum alkaline phosphatase in skeletal and hepatobiliary disease.
    Leroux M; Perry WF
    Clin Biochem; 1972 Dec; 5(4):201-7. PubMed ID: 4640822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extrahepatic bile duct stimulation by morphine and serum enzyme changes in various liver diseases].
    Lenti G; Emanuelli G; Verzetti G
    Quad Sclavo Diagn; 1972 Mar; 8(1):216-28. PubMed ID: 4663752
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical biochemistry of alkaline phosphatase.
    Moss DW
    Cell Biochem Funct; 1983 Jul; 1(2):70-4. PubMed ID: 6383643
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity of human serum alkaline phosphatase, as investigated by molecular filtration through Sephadex G-200.
    Gabryƛ K
    Pol Med J; 1971; 10(5):1112-8. PubMed ID: 5133660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biliary tract diseases and their effects on the liver].
    Petzold H
    Dtsch Z Verdau Stoffwechselkr; 1974; 34(2-4):93-7. PubMed ID: 4282353
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intestinal alkaline phosphatase in some chronic diseases of the hepato-biliary system].
    Bakhadyrov KB; Kakharbekov KK; Beiul EA; Cherenok ZF
    Ter Arkh; 1969 Dec; 41(12):44-6. PubMed ID: 5382752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of leucine aminopeptidase activity in the blood serum in diseases of the hepatobiliary system].
    Loginov AS; Baranovskaia NI; Isakova ZS; Kuvaeva IB
    Klin Med (Mosk); 1972 Dec; 50(12):41-4. PubMed ID: 4660501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gamma-glutamyl transpeptidase values in liver and bile duct diseases. Clinical observations and experimental trials].
    Bertrand L; Arnefaux J
    Ann Med Interne (Paris); 1973 Mar; 124(3):173-80. PubMed ID: 4146099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum gamma-glutamyl transpeptidase: a sensitive indicator in hepatobiliary disorders].
    Kammeraat C
    Ned Tijdschr Geneeskd; 1970 Oct; 114(44):1814-6. PubMed ID: 5471995
    [No Abstract]   [Full Text] [Related]  

  • 15. [A modification of the method of determining alkaline phosphatase activity for the diagnosis of diseases of the liver and bile ducts].
    Kolmakov VN; Kuleba VA; Chamin NN
    Sov Med; 1968 Aug; 31(8):58-61. PubMed ID: 5733428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of determination of -glutamyl transpeptidase ( -GT) in hepatobiliary diseases].
    Saragoni A; Gardini G; Lazzari L; Savoia M
    Quad Sclavo Diagn; 1972 Mar; 8(1):368-73. PubMed ID: 4145982
    [No Abstract]   [Full Text] [Related]  

  • 17. Profiles of serum isoenzymes of alkaline phosphatase in hepatobiliary disorders using cellulose acetate electrophoresis and organ-specific inhibitors.
    Rhone DP; Mizuno FM; Gidaspow H
    Ann Clin Lab Sci; 1973; 3(5):353-61. PubMed ID: 4756765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Real value of the determination of gamma glutamyl transpeptidase activity in hepatobiliary pathology. Apropos of 5,000 determinations].
    Lafargue P; Couture JC; Ponsot P
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1697-8. PubMed ID: 8768
    [No Abstract]   [Full Text] [Related]  

  • 19. [The glutamic pyruvic transaminase-alkaline phosphatase quotient in hepatic pathology].
    Ledro Molina D
    Rev Esp Enferm Apar Dig; 1974 Mar; 43(2):183-92. PubMed ID: 4840487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum glutamyl transpeptidase activity in liver and biliary tract diseases].
    Terletskaia LM
    Vrach Delo; 1981 Oct; (10):69-72. PubMed ID: 6117984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.